{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:46:11Z","timestamp":1792554371468,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["YY053"],"award-info":[{"award-number":["YY053"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673830"],"award-info":[{"award-number":["81673830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2017zx09101001005"],"award-info":[{"award-number":["2017zx09101001005"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116889","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:40:38Z","timestamp":1779306038000},"page":"116889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["All-trans retinoic acid and lansoprazole potentiated NKG2D-CAR T for breast cancer treatment"],"prefix":"10.1016","volume":"183","author":[{"given":"Tianchi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixia","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116889_bb0005","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/2326-6066.CIR-24-0246","article-title":"Augmenting CAR T-cell functions with LIGHT","volume":"12","author":"Cai","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2026.116889_bb0010","article-title":"FDA-approved chimeric antigen receptor (CAR)-T cell therapy for different cancers-a recent perspective","author":"Thirumalaisamy","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.intimp.2026.116889_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114301","article-title":"Modulating tumor physical microenvironment for fueling CAR-T cell therapy","volume":"185","author":"Luo","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2026.116889_bb0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116889_bb0025","first-page":"228","article-title":"Target selection of CAR T cell therapy in accordance with the TME for solid tumors","volume":"9","author":"Liu","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116889_bb0030","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.3390\/cancers14163906","article-title":"Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy","volume":"14","author":"Glabman","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.116889_bb0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/0008-5472.CAN-16-0866","article-title":"Targeting tumor-associated fibroblasts for therapeutic delivery in desmoplastic tumors","volume":"77","author":"Miao","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116889_bb0040","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/acs.nanolett.6b04150","article-title":"Protein nanocage mediated fibroblast-activation protein targeted photoimmunotherapy to enhance cytotoxic T cell infiltration and tumor control","volume":"17","author":"Zhen","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.intimp.2026.116889_bb0045","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1039\/D0BM01878C","article-title":"On-demand responsive nanoplatform mediated targeting of CAFs and down-regulating mtROS-PYK2 signaling for antitumor metastasis","volume":"9","author":"Zuo","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.intimp.2026.116889_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006130","article-title":"Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6","volume":"11","author":"Lee","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.116889_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12630","article-title":"ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion","volume":"7","author":"Chronopoulos","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116889_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cbi.2018.02.021","article-title":"Synergistic and additive effects of ATRA in combination with different anti-tumor compounds","volume":"285","author":"Schultze","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2026.116889_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz247.027","article-title":"700P - STAR-PAC: phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer","volume":"30","author":"Kocher","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2026.116889_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18636-w","article-title":"Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer","volume":"11","author":"Kocher","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116889_bb0075","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/1078-0432.CCR-19-1835","article-title":"Enhancing chimeric antigen receptor T-cell efficacy in solid tumors","volume":"26","author":"Fuc\u00e0","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116889_bb0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","article-title":"Engineering CAR-T cells for next-generation cancer therapy","volume":"38","author":"Hong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116889_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1208870","article-title":"Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy","volume":"14","author":"Tao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116889_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s42255-022-00730-6","article-title":"Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness","volume":"5","author":"Cheng","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.intimp.2026.116889_bb0095","doi-asserted-by":"crossref","DOI":"10.4161\/onci.22058","article-title":"The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors","volume":"2","author":"Bellone","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.intimp.2026.116889_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drup.2015.08.004","article-title":"Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach","volume":"23","author":"Taylor","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2026.116889_bb0105","article-title":"A hierarchical structured fiber device remodeling the acidic tumor microenvironment for enhanced cancer immunotherapy","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2026.116889_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-12-24","article-title":"NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study","volume":"12","author":"de Kruijf","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2026.116889_bb0115","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.3390\/ijms25074126","article-title":"Soluble NKG2DLs are elevated in breast cancer patients and associate with disease outcome","volume":"25","author":"Seller","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116889_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116889_bb0125","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/djh305","article-title":"Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs","volume":"96","author":"Luciani","year":"2004","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.intimp.2026.116889_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121341","article-title":"IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy","volume":"281","author":"Luo","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116889_bb0135","first-page":"1","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116889_bb0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imr.12982","article-title":"Cancer-associated fibroblasts: key players in shaping the tumor immune microenvironment","volume":"302","author":"Desbois","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2026.116889_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176374","article-title":"Retinoic acid signaling pathway in pancreatic stellate cells: insight into the anti-fibrotic effect and mechanism","volume":"967","author":"Sun","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116889_bb0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm3932","article-title":"Mechanisms of retinoic acid signalling and its roles in organ and limb development","volume":"16","author":"Cunningham","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.116889_bb0155","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2011.06.047","article-title":"Retinoic acid\u2013induced pancreatic stellate cell quiescence reduces paracrine wnt\u2013\u03b2-catenin signaling to slow tumor progression","volume":"141","author":"Froeling","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2026.116889_bb0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.drudis.2009.03.014","article-title":"Proton pump inhibitors: actions and reactions","volume":"14","author":"Mullin","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2026.116889_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","article-title":"The acidic tumor microenvironment as a driver of cancer","volume":"82","author":"Boedtkjer","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.intimp.2026.116889_bb0170","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12935-024-03520-0","article-title":"Acid affairs in anti-tumour immunity","volume":"24","author":"Cappellesso","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2026.116889_bb0175","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1038\/s44318-024-00235-w","article-title":"Acidity suppresses CD8+T-cell function by perturbing IL-2, mTORC1, and c-myc signaling","volume":"43","author":"Vuillefroy de Silly","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2026.116889_bb0180","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1182\/blood-2004-12-4906","article-title":"Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection","volume":"106","author":"Moeller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116889_bb0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.33696\/cancerimmunol.6.080","article-title":"Enhancing the efficacy of CAR-T cell therapy: a comprehensive exploration of cellular strategies and molecular dynamics","volume":"6","author":"Baysal","year":"2024","journal-title":"J. Cancer Immunol."},{"key":"10.1016\/j.intimp.2026.116889_bb0190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ni.2536","article-title":"Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation","volume":"14","author":"Best","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.116889_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba8426","article-title":"All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages","author":"Rao","year":"2021","journal-title":"Sci. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:43:53Z","timestamp":1783161833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926007356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S1567576926007356"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116889","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All-trans retinoic acid and lansoprazole potentiated NKG2D-CAR T for breast cancer treatment","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116889"}}